MedPath

TacTIC- Trans-disciplinary Chronic Disease Continuity of Care Model

Not Applicable
Withdrawn
Conditions
Geriatrics
Chronic Disease
Registration Number
NCT02398851
Lead Sponsor
Hackensack Meridian Health
Brief Summary

The overall aim of this study is to create a trans-disciplinary chronic disease continuity of care model with health information technology, utilizing mobile devices such as tablets, iPads and smartphones.

Detailed Description

This study aims to explore if a trans-disciplinary chronic disease continuity of care model with integrated technology (mobile devices such as tablets, iPads and smartphones) to standard practice (patient-centered, coordinated care model without the integration of technology) will results in a reduction in 30-day readmission rate in adult patients.

Recruitment & Eligibility

Status
WITHDRAWN
Sex
All
Target Recruitment
Not specified
Inclusion Criteria
  • Adult patients on a 43 bed medical surgical unit
  • Adult patients on 44 bed geriatric unit
Exclusion Criteria
  • Adult patients admitted and not diagnosed with chronic disease
  • Patients who are transferred between Intervention and non-Intervention unit
  • Patients who refuse
  • Patients with delirium, dementia and altered mental status
  • Patients who cannot read and write in any language
  • Patients in the intervention group who cannot use mobile technology

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Reduction in the 30-day readmission rates in adult patients who receive care in a trans-disciplinary chronic disease continuity of care model integrated with technology (mobile devices such as tablets, iPads and smartphones).30 days
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Hackensack University Medical center

🇺🇸

Hackensack, New Jersey, United States

Hackensack University Medical center
🇺🇸Hackensack, New Jersey, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.